HK1021372A1 - Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists - Google Patents

Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Info

Publication number
HK1021372A1
HK1021372A1 HK99106019A HK99106019A HK1021372A1 HK 1021372 A1 HK1021372 A1 HK 1021372A1 HK 99106019 A HK99106019 A HK 99106019A HK 99106019 A HK99106019 A HK 99106019A HK 1021372 A1 HK1021372 A1 HK 1021372A1
Authority
HK
Hong Kong
Prior art keywords
acylaminoalkenylene
antagonists
amide derivatives
amide
derivatives
Prior art date
Application number
HK99106019A
Other languages
English (en)
Inventor
Marc Gerspacher
Sprecher Andreas Von
Robert Mah
Silvio Roggo
Stefan Stutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1021372A1 publication Critical patent/HK1021372A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12Nitrogen atoms not forming part of a nitro radical
HK99106019A 1996-08-22 1999-12-21 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists HK1021372A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH206196 1996-08-22
PCT/EP1997/004436 WO1998007694A1 (en) 1996-08-22 1997-08-13 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Publications (1)

Publication Number Publication Date
HK1021372A1 true HK1021372A1 (en) 2000-06-09

Family

ID=4225003

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99106019A HK1021372A1 (en) 1996-08-22 1999-12-21 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Country Status (32)

Country Link
US (1) US6319917B1 (es)
EP (1) EP0923550B1 (es)
JP (1) JP3654908B2 (es)
KR (1) KR100467402B1 (es)
CN (1) CN1119328C (es)
AR (1) AR009266A1 (es)
AT (1) ATE224875T1 (es)
AU (1) AU721850B2 (es)
BR (1) BR9711350A (es)
CA (1) CA2264065C (es)
CO (1) CO4900047A1 (es)
CZ (1) CZ294233B6 (es)
DE (1) DE69715886T2 (es)
DK (1) DK0923550T3 (es)
ES (1) ES2184083T3 (es)
HK (1) HK1021372A1 (es)
HU (1) HU226395B1 (es)
ID (1) ID18059A (es)
IL (1) IL128631A (es)
MY (1) MY132550A (es)
NO (1) NO312292B1 (es)
NZ (1) NZ334736A (es)
PE (1) PE107498A1 (es)
PL (1) PL193731B1 (es)
PT (1) PT923550E (es)
RU (1) RU2185375C2 (es)
SI (1) SI0923550T1 (es)
SK (1) SK283991B6 (es)
TR (1) TR199900363T2 (es)
TW (1) TW438777B (es)
WO (1) WO1998007694A1 (es)
ZA (1) ZA977493B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281300B1 (en) * 1998-03-20 2001-08-28 Exxon Chemical Patents, Inc. Continuous slurry polymerization volatile removal
GB0010958D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
GB0203061D0 (en) 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB2394417A (en) * 2002-10-24 2004-04-28 Novartis Ag Solid dispersion comprising a piperidine substance P antagonist and a carrier
GB0224788D0 (en) * 2002-10-24 2002-12-04 Novartis Ag Organic compounds
WO2005039563A2 (en) * 2003-10-27 2005-05-06 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
TWI356821B (en) * 2003-12-01 2012-01-21 Cambridge Entpr Ltd Anti-inflammatory agents
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
GB0607532D0 (en) * 2006-04-13 2006-05-24 Novartis Ag Organic compounds
JO2630B1 (en) * 2006-04-13 2012-06-17 نوفارتيس ايه جي Organic compounds
EP1938804A1 (en) * 2006-12-22 2008-07-02 Novartis AG Pharmaceutical formulation comprising neurokinin antagonist
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
BRPI1008008A2 (pt) * 2009-02-24 2016-02-23 Novartis Ag usos de antagonistas do receptor de nk
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110514A1 (en) 1991-07-05 1993-01-21 Raymond Baker Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
EP0716077A1 (de) * 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
NZ300942A (en) 1995-02-22 1998-12-23 Novartis Ag 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists

Also Published As

Publication number Publication date
NO312292B1 (no) 2002-04-22
EP0923550B1 (en) 2002-09-25
CN1119328C (zh) 2003-08-27
SI0923550T1 (en) 2003-02-28
ID18059A (id) 1998-02-26
HUP0001165A2 (hu) 2000-11-28
SK22199A3 (en) 2000-02-14
RU2185375C2 (ru) 2002-07-20
TR199900363T2 (xx) 1999-04-21
KR100467402B1 (ko) 2005-01-24
AR009266A1 (es) 2000-04-12
PT923550E (pt) 2003-01-31
CZ294233B6 (cs) 2004-11-10
AU4299397A (en) 1998-03-06
ZA977493B (en) 1998-08-03
PL331740A1 (en) 1999-08-02
CA2264065A1 (en) 1998-02-26
HU226395B1 (en) 2008-11-28
CA2264065C (en) 2008-02-05
SK283991B6 (sk) 2004-07-07
KR20000068325A (ko) 2000-11-25
IL128631A0 (en) 2000-01-31
US6319917B1 (en) 2001-11-20
HUP0001165A3 (en) 2002-02-28
JP3654908B2 (ja) 2005-06-02
PE107498A1 (es) 1999-01-28
DK0923550T3 (da) 2003-01-06
CZ58199A3 (cs) 1999-06-16
CO4900047A1 (es) 2000-03-27
NO990786L (no) 1999-03-25
PL193731B1 (pl) 2007-03-30
NO990786D0 (no) 1999-02-19
WO1998007694A1 (en) 1998-02-26
DE69715886T2 (de) 2003-05-15
CN1233238A (zh) 1999-10-27
NZ334736A (en) 2000-09-29
DE69715886D1 (de) 2002-10-31
ATE224875T1 (de) 2002-10-15
EP0923550A1 (en) 1999-06-23
BR9711350A (pt) 1999-08-17
TW438777B (en) 2001-06-07
MY132550A (en) 2007-10-31
AU721850B2 (en) 2000-07-13
ES2184083T3 (es) 2003-04-01
IL128631A (en) 2002-09-12
JP2001503387A (ja) 2001-03-13

Similar Documents

Publication Publication Date Title
HK1003884A1 (en) Quinoline derivatives as tachykinin nk3 receptor and antagonists
HU9603525D0 (en) Vironectin receptor antagonists
GB9625020D0 (en) Network restoration
EP0912175A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
IL130660A0 (en) Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them
CY2505B1 (en) Quinoline derivatives as nk3 antagonists
ZA97209B (en) Substituted aza- and diacycloheptane and -cyclooctane compounds and their use
GB9625843D0 (en) Phenyl spiroethercycloalkyl tachykinn receptor antagonists
EP0885205A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0885213A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
IL128631A0 (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
IL129096A0 (en) Substituted heterocycles as anti-tumor agents
EP0796098A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
HU9503191D0 (en) Adhesion-receptor antagonists
PL333079A1 (en) Piparazinic derivatives as antagonists of neurokinin
EP0794779A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0941111A4 (en) HEPATOCYTE GROWTH FACTOR ANTAGONISTS
EP0781133A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0928194A4 (en) COMPOSITIONS AND METHODS FOR ADMINISTERING INTEGRIN RECEPTOR ANTAGONISTS
EP0957908A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
GB9708766D0 (en) Fibrinogen receptor antagonist
GB9621902D0 (en) Neurotrophin antagonist compositions
GB9626308D0 (en) av›3 antagonists
TW315661U (en) Cylinder chair
GB9601116D0 (en) Stool

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120813